ORYZON will provide updates on the company’s progress at several events in September Page 1

• German Autumn Conference 2024
• European College of Neuropsychopharmacology (ECNP) Congress 2024
• Sachs Annual Biotech in Europe Forum 2024

MADRID, Spain and CAMBRIDGE, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) — Oryzon Genomics, SA (ISIN: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies for diseases with high unmet medical need, today announced that management will provide an update on the company’s progress at several international events in September.

Oryzon will attend the German Autumn Conference 2024, which will be held on September 2-3 at the Le Meridien Hotel in Frankfurt, Germany. The company will provide a corporate update and hold one-on-one meetings with fellow companies and global investors on September 3 at 13:45 CET. Click on the link for more information about the German Autumn Conference 2024